T160-0832 Screening compound: 4-({4-[(5-methyl-1-propyl-1H-imidazol-2-yl)methyl]piperidin-1-yl}sulfonyl)-2,1,3-benzothiadiazole

T160-0832 Screening compound: 4-({4-[(5-methyl-1-propyl-1H-imidazol-2-yl)methyl]piperidin-1-yl}sulfonyl)-2,1,3-benzothiadiazole
T160-0832 Screening compound: 4-({4-[(5-methyl-1-propyl-1H-imidazol-2-yl)methyl]piperidin-1-yl}sulfonyl)-2,1,3-benzothiadiazole alternative view

Chemical Structure Depiction of ChemDiv screening compound T160-0832
4-({4-[(5-methyl-1-propyl-1H-imidazol-2-yl)methyl]piperidin-1-yl}sulfonyl)-2,1,3-benzothiadiazole

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

T160-0832

Molecular Formula

C19H25N5O2S2 (C19 H25 N5 O2 S2)

Compound Name

4-({4-[(5-methyl-1-propyl-1H-imidazol-2-yl)methyl]piperidin-1-yl}sulfonyl)-2,1,3-benzothiadiazole

IUPAC name

4-({4-[(5-methyl-1-propyl-1H-imidazol-2-yl)methyl]piperidin-1-yl}sulfonyl)-213-benzothiadiazole

SMILES

CCCn1c(CC(CC2)CCN2S(c2cccc3nsnc23)(=O)=O)ncc1C

InChI

InChI=1S/C19H25N5O2S2/c1-3-9-24-14(2)13-20-18(24)12-15-7-10-23(11-8-15)28(25,26)17-6-4-5-16-19(17)22-27-21-16/h4-6,13,15H,3,7-12H2,1-2H3

InChI Key

SXBQGXIDYQCPAW-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD29016342

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

419.57

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

3.614

Distribution Coefficient, logD

1.412

Water Solubility, LogSw

-3.49

Polar Surface Area

65.041

Acid Dissociation Constant (pKa)

25.41

Base Dissociation Constant (pKb)

9.60

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

52.60

T160-0832 in Drug Discovery

Included in Screening Libraries

Antiviral Library (67538 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

CNS Targets (44014 compounds)

Eccentric PPI Library (11937 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein-Protein Interaction Library (218420 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Nervous system
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Cyclic compounds
  • Mimetics

References: we are preparing a list of scientific research reports with T160-0832 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound T160-0832?
Check Price and Availability of T160-0832, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of T160-0832 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for T160-0832
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for T160-0832
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of T160-0832 available by request